References
- 1 J. Bruix and M. Sherman, Management of hepatocellular carcinoma: An update, Hepatology53 (2011) 1020–1022; https://doi.org/10.1002/hep.2419910.1002/hep.24199308499121374666
- 2. U. Asghar and T. Meyer, Are there opportunities for chemotherapy in the treatment of hepatocellular cancer? J. Hepatol.56 (2012) 686–695; https://doi.org/10.1016/j.jhep.2011.07.03110.1016/j.jhep.2011.07.03121971559
- 3. S. R. Chen, H.C. Qiu, Y. Hu, Y. Wang and Y. T. Wang, Herbal medicine offered as an initiative therapeutic option for the management of hepatocellular carcinoma, Phytother. Res.30 (2016) 863–877; https://doi.org/10.1002/ptr.559410.1002/ptr.559426879574
- 4. B. Kocaadam and N. Sanlier, Curcumin, an active component of turmeric (Curcuma longa), and its effects on health, Crit. Rev. Food Sci. Nutr.57 (2017) 2889–2895; https://doi.org/10.1080/10408398.2015.107719510.1080/10408398.2015.107719526528921
- 5. H. Mahammedi, E. Planchat, M. Pouget, X. Durando, H. Cure, L. Guy, I. Van-Praagh, L. Savareux, M. Atger, M. Bayet-Robert, E. Gadea, C. Abrial, E. Thivat, P. Chollet and J. C. Eymard, The new combination docetaxel, prednisone and curcumin in patients with castration-resistant prostate cancer: A Pilot Phase II Study, Oncology90 (2016) 69–78; https://doi.org/10.1159/00044114810.1159/00044114826771576
- 6. W. Z. Wang, L. Li, M. Y. Liu, X. B. Jin, J. W. Mao, Q. H. Pu, M. J. Meng, X. G. Chen and J. Y. Zhu, Curcumin induces FasL-related apoptosis through p38 activation in human hepatocellular carcinoma Huh7 cells, Life Sci.92 (2013) 352–358; https://doi.org/doi:10.1016/j.lfs.2013.01.01310.1016/j.lfs.2013.01.01323352975
- 7. M. I. James, C. Iwuji, G. Irving, A. Karmokar, J. A. Higgins, N. Griffin-Teal, A. Thomas, P. Greaves, H. Cai, S. R. Patel, B. Morgan, A. Dennison, M. Metcalfe, G. Garcea, D. M. Lloyd, D. P. Berry, W. P. Steward, L. M. Howells and K. Brown, Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy, Cancer Lett.364 (2015) 135–141; https://doi.org/10.1016/j.canlet.2015.05.00510.1016/j.canlet.2015.05.005451014425979230
- 8. R. A. Sharma, S. A. Euden, S. L. Platton, D. N. Cooke, A. Shafayat, H. R. Hewitt, T. H. Marczylo, B. Morgan, D. Hemingway, S. M. Plummer, M. Pirmohamed, A. J. Gescher and W. P. Steward, Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance, Clin. Cancer Res.10 (2004) 6847–6854; https://doi.org/10.1158/1078-0432.CCR-04-074410.1158/1078-0432.CCR-04-074415501961
- 9. D. Ghosh, S. T. Choudhury, S. Ghosh, A. K. Mandal, S. Sarkar, A. Ghosh, K. D. Saha and N. Das, Nanocapsulated curcumin: oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat, Chem. Biol. Int.195 (2012) 206–214; https://doi.org/10.1016/j.cbi.2011.12.00410.1016/j.cbi.2011.12.00422197969
- 10. F. Wang, J. Chen, W. Dai, Z. He, D. Zhai and W. Chen, Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers, Acta Pharm.67 (2017) 597–605; https://doi.org/10.1515/acph-2017-002110.1515/acph-2017-002128858837
- 11. F. Wang, Z. He, W. Dai, Q. Li, X. Liu, Z. Zhang, D. Zhai, J. Chen and W. Chen, The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis, J. Cancer Res. Ther.11 (2015) 597–605; https://doi.org/10.4103/0973-1482.15908610.4103/0973-1482.159086
- 12. S. Fulda, Targeting apoptosis for anticancer therapy, Semin. Cancer Biol.31 (2015) 84–88. https://doi.org/10.1016/j.semcancer.2014.05.00210.1016/j.semcancer.2014.05.002
- 13. F. C. Kischkel, D. A. Lawrence, A. Chuntharapai, P. Schow, K. J. Kim and A. Ashkenazi, Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5, Immunity12 (2000) 611–620; https://doi.org/10.1016/s1074-7613(00)80212-510.1016/S1074-7613(00)80212-5
- 14. J. Chen, W. T. Dai, Z. M. He, L. Gao, X. Huang, J. M. Gong, H. Y. Xing and W. D. Chen, Fabrication and evaluation of curcumin-loaded nanoparticles based on solid lipid as a new type of colloidal drug delivery system, Indian J. Pharm. Sci.75 (2013) 178–184.
- 15. J. Li and J. Yuan, Caspases in apoptosis and beyond, Oncogene27 (2008) 6194–6206. https://doi.org/10.1038/onc.2008.29710.1038/onc.2008.29718931687